- Home
- PTCT vs NGD Comparison
PTCT vs NGD Comparison
Compare PTCT & NGD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTCT
- NGD
- Stock Information
- Founded
- PTCT 1998
- NGD N/A
- Country
- PTCT United States
- NGD Canada
- Employees
- PTCT N/A
- NGD N/A
- Industry
- PTCT Biotechnology: Pharmaceutical Preparations
- NGD
- Sector
- PTCT Health Care
- NGD
- Exchange
- PTCT Nasdaq
- NGD Nasdaq
- Market Cap
- PTCT 5.3B
- NGD 3.9B
- IPO Year
- PTCT 2013
- NGD 2004
- Fundamental
- Price
- PTCT $71.58
- NGD $7.01
- Analyst Decision
- PTCT Buy
- NGD Buy
- Analyst Count
- PTCT 17
- NGD 2
- Target Price
- PTCT $73.24
- NGD $8.75
- AVG Volume (30 Days)
- PTCT 1.0M
- NGD 23.5M
- Earning Date
- PTCT 11-04-2025
- NGD 10-28-2025
- Dividend Yield
- PTCT N/A
- NGD N/A
- EPS Growth
- PTCT N/A
- NGD 1232.42
- EPS
- PTCT 8.94
- NGD 0.31
- Revenue
- PTCT $1,779,150,000.00
- NGD $1,242,200,000.00
- Revenue This Year
- PTCT $119.02
- NGD $57.60
- Revenue Next Year
- PTCT N/A
- NGD $59.57
- P/E Ratio
- PTCT $8.03
- NGD $22.32
- Revenue Growth
- PTCT 97.54
- NGD 44.19
- 52 Week Low
- PTCT $35.95
- NGD $2.43
- 52 Week High
- PTCT $73.98
- NGD $7.71
- Technical
- Relative Strength Index (RSI)
- PTCT 71.08
- NGD 53.32
- Support Level
- PTCT $66.10
- NGD $6.61
- Resistance Level
- PTCT $73.98
- NGD $7.19
- Average True Range (ATR)
- PTCT 2.58
- NGD 0.37
- MACD
- PTCT 0.10
- NGD -0.01
- Stochastic Oscillator
- PTCT 70.62
- NGD 58.82
About PTCT PTC Therapeutics Inc.
PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.
About NGD New Gold Inc.
New Gold Inc participates in the development and operation of intermediate mining properties. The company has a portfolio of two primary assets which are also its operating segments: the Rainy River Mine and the New Afton Mine in Canada. The company also owns the Cerro San Pedro Mine in Mexico. The company derives revenue from the sale of gold, copper, and silver.